Watch ISD Live Now Listen to ISD Radio Now

Indian firm to collaborate with US company for developing coronavirus vaccine

As all countries across the world are focusing on developing a coronavirus vaccine, India too has taken a number of major initiatives in this regard. India’s Biotechnology major Panacea Biotech said on Wednesday that it is collaborating with Refana Inc of the United States to make a COVID 19 vaccine. The collaboration is reportedly targeted at making a coronavirus vaccine that is widely accessible throughout the world in an equitable manner through a joint venture company to be based in Ireland.

Under this collaboration, the Indian company Panacea Biotech will be responsible for product development and commercial manufacturing while the joint venture will take care of clinical development and regulatory submissions across the world. Both companies will undertake sales and distribution of the vaccine in their respective areas.

Serum Institute of India, known as the world’s largest vaccine manufacturer is also investing 100 million USD on a potential COVID 19 vaccine being developed at Oxford University, as per various media reports. The Indian company has partnered with AstraZeneca, a British biopharma giant, to ensure equitable supply of the vaccine doses to India as well as low and middle income countries.

Besides, Indian company Bharat Biotech is also developing a COVID 19 vaccine in collaboration with the Indian Council of Medical Research (ICMR ) and the Thomas Jefferson University of Philadelphia.

While on the one hand, there is a race amongst different countries for the development of a potential COVID 19 vaccine, many research studies are also talking about the efficacy of traditional or alternative medicine systems like Ayurveda in preventing and possibly, curing COVID 19. Indian Institute of Technology, Delhi and Japan’s National institute of Advanced Industrial Science and Technology have done  a joint study that talks about the potential efficacy of traditional Indian herb Ashwagandha in curing COVID  19.Many traditional  ayurvedic herbs have a proven efficacy when it comes to strengthening a person’s immune system.

Join our Telegram Community to ask questions and get latest news updates
आदरणीय पाठकगण,

ज्ञान अनमोल हैं, परंतु उसे आप तक पहुंचाने में लगने वाले समय, शोध, संसाधन और श्रम (S4) का मू्ल्य है। आप मात्र 100₹/माह Subscription Fee देकर इस ज्ञान-यज्ञ में भागीदार बन सकते हैं! धन्यवाद!  

Select Subscription Plan

OR

Make One-time Subscription Payment

Select Subscription Plan

OR

Make One-time Subscription Payment

Other Amount: USD



Bank Details:
KAPOT MEDIA NETWORK LLP
HDFC Current A/C- 07082000002469 & IFSC: HDFC0000708  
Branch: GR.FL, DCM Building 16, Barakhamba Road, New Delhi- 110001
SWIFT CODE (BIC) : HDFCINBB
Paytm/UPI/Google Pay/ पे / Pay Zap/AmazonPay के लिए - 9312665127
WhatsApp के लिए मोबाइल नं- 9540911078

Rati Agnihotri

Rati Agnihotri

रति अंग्रेज़ी और हिंदी दोनों में कवितायें लिखती हैं. इनका अंग्रेज़ी का पहला कविता संग्रह ‘ द सनसेट सोनाटा’साहित्य अकादमी से प्रकाशित हुआ है. रति की हिंदी कवितायें पाखी, संवदिया, परिकथा, रेतपथ, युद्धरत आम आदमी, हमारा भारत आदि साहित्यिक पत्रिकाओं में प्रकाशित हो चुकी हैं. रति दिल्ली में ‘ मूनवीवर्स – चांद के जुलाहे’ के नाम से एक पोएट्री ग्रुप चलाती हैं जहां कविता को संगीत, चित्रकला आदि विभिन्न विधाओं से जोड़ा जाता है और कविता से जुड़े विभिन्न पहलुओं पर विचार भी होता है. रति चीन के शिनुआ न्यूज़ एजेंसी के नई दिल्ली ब्यूरो में बतौर टी वी न्यूज़ रिपोर्टर कार्य कर चुकी हैं. रति आजकल स्वतंत्र पत्रकार के रूप में कार्यरत हैं. रति ने दिल्ली विश्वविद्यालय के मिरांडा हाउस कांलेज से अंग्रेज़ी विशेष में बी ए आनर्स किया है और इंग्लैंड के लीड्स विश्वविद्यालय से अंतराष्ट्रीय पत्रकारिता में एम ए किया है.

You may also like...

Write a Comment

ताजा खबर